McKesson Corporation (MCK) has shown consistent growth and gained attention from investors as its stock surges. Their recent moves include the strategic
acquisition of Core Ventures and
PRISM Vision Holdings, LLC. These moves were made to improve community oncology access and add a high-growth business, respectively. Additionally,
McKesson has announced the spin-off of its Medical-Surgical Solutions Business, which analysts perceive as a positive move.
MCK's financial performance has been robust, with strong
Q3 2025 earnings highlighting substantial revenue growth. This strong performance is reflected in Wells Fargo and Mizuho adjusting their price targets on
McKesson to $766 and $735, respectively. Despite some insiders, such as Thomas Rodgers and Leann Smith, selling their MCK shares, the company continues to elicit optimism amongst Wall Street analysts. The company's ongoing trend, combined with a positive growth outlook, makes
McKesson an attractive investment proposition.
Mckesson Corporation MCK News Analytics from Wed, 23 Oct 2024 07:00:00 GMT to Sat, 07 Jun 2025 14:57:40 GMT -
Rating 7
- Innovation 6
- Information 8
- Rumor -2
